However, recognising that some patients may be unwilling or unable to stop completely, harm reduction strategies can minimise risks: Harm reduction approaches: Reduce frequency and dose : Limiting cannabis use to occasional rather than daily consumption, and using lower doses, may reduce appetite stimulation and other interfering effects whilst acknowledging that any use carries potential risks
Furthermore, several GLP-1 medications are due to go off patent in certain countries such as Canada and India in 2026, meaning that generics and biosimilars will become more prevalent, further lowering costs
Rybelsus (oral semaglutide): The first oral GLP-1 RA, offering an alternative administration route
Most of us are consuming ultra-processed foods with many refined carbohydrates and sugars, and those are making us sick
Lifestyle is the foundation
and Spirulina platensis : a promising feedstock for various applications